Intracranial tumors can be resected safely in elderly

Intracranial tumors can be resected safely in elderly
Elderly patients do not have poorer short-term outcomes after surgical resection of primary or metastatic intracranial tumors, after accounting for other risk factors, according to research published online Oct. 12 in Cancer.

(HealthDay)—Elderly patients do not have poorer short-term outcomes after surgical resection of primary or metastatic intracranial tumors, after accounting for other risk factors, according to research published online Oct. 12 in Cancer.

Andreea Seicean, M.P.H., of the Case Western Reserve University School of Medicine in Cleveland, and colleagues conducted a prospective study using data from the American College of Surgeons' National -Improvement Project database from 2006 to 2010. Outcomes were assessed for 134 patients aged 75 years and older and 134 -matched patients aged 40 to 74 years of age who underwent craniotomy for resection of .

The researchers found no increase in the odds for poorer short-term outcomes with advanced age. There were no significant differences in minor or major complications between the groups, and no significant differences in return to the operating room or 30-day mortality.

"Contrary to common assumptions, our analysis of a large, prospective, multi-institutional database suggests that advanced age does not predispose individuals undergoing aggressive surgical therapy for primary or metastatic intracranial tumor to increased risk for operative or short-term postoperative morbidity or mortality," the authors write.

More information: Abstract
Full Text (subscription or payment may be required)

add to favorites email to friend print save as pdf

Related Stories

Nonoperative approach feasible in advanced colon cancer

Aug 09, 2012

(HealthDay) -- Treating patients with surgically unresectable metastatic colon cancer and an asymptomatic intact primary tumor with bevacizumab and infusional fluorouracil, leucovorin, and oxaliplatin (mFOLFOX6) ...

Recommended for you

How a common antacid could lead to cheaper anti-cancer drugs

28 minutes ago

A popular indigestion medication can increase survival in colorectal cancer, according to research published in ecancermedicalscience. But in fact, scientists have studied this for years - and a group of cancer advocates want t ...

Vaccines may make war on cancer personal

39 minutes ago

In the near future, physicians may treat some cancer patients with personalized vaccines that spur their immune systems to attack malignant tumors. New research led by scientists at Washington University ...

Funding to investigate an alternative to chemotherapy

1 hour ago

Professor Simon Rule, Professor in Haematology at Plymouth University Peninsula Schools of Medicine and Dentistry and Consultant Haematologist at Plymouth Hospitals NHS Trust, has been awarded a significant grant by Cancer ...

Enzyme may be key to cancer progression in many tumors

1 hour ago

Mutations in the KRAS gene have long been known to cause cancer, and about one third of solid tumors have KRAS mutations or mutations in the KRAS pathway. KRAS promotes cancer formation not only by driving ...

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.